Reporter November 2023
-
November 28, 2023
Marshall named Vice President and Chief Operating Officer for Ambulatory Surgery Division
Stephen W. Marshall, MBA, Senior Vice president of Operations for Surgery Partners, has been named as Vice President and Chief Operating Officer for Vanderbilt Health System’s Ambulatory Surgery Division. -
November 27, 2023
Ukrainian doctors again visit VUMC to observe organ transplants and protocols
For the second year, a delegation of doctors from Ukraine recently visited Vanderbilt University Medical Center to observe organ transplants and protocols. -
November 27, 2023
Sondra Hornsey named as VUMC’s Chief Privacy Officer
Sondra Hornsey, MSEd, CHPC, Interim Chief Compliance and Privacy Officer for Stanford Health Care and Stanford Children’s Hospital, has been named as Vanderbilt University Medical Center’s new Chief Privacy Officer. She will join VUMC on Dec. 4. -
November 22, 2023
National study of two surgical interventions for exotropia shows no detectable difference
A study comparing two surgical methods for repairing childhood intermittent exotropia (a common form of strabismus or eye misalignment, in which one or both eyes sometimes turn outward) were unable to detect a significant difference in the two methods. -
November 21, 2023
Commensal gut bacterium protects from severe intestinal infection
The commensal bacterium Turicibacter sanguinis could be used to protect against severe intestinal infections, Vanderbilt researchers discovered. -
November 21, 2023
Young patient’s recovery from infection, multiple amputations, moves to next phase
After 143 days in the Pediatric Intensive Care Unit at Monroe Carell Jr. Children’s Hospital at Vanderbilt, Mathias Uribe was discharged to begin the next phase of his recovery following a lengthy infection that led to a rare sequence of health issues. -
November 21, 2023
VUMC scientists discover key step to kidney fibrosis
Researchers at Vanderbilt University Medical Center for the first time have shown that activation of the epidermal growth factor receptor (EGFR) is essential for the development of kidney fibrosis, tissue scarring following injury that can lead to kidney failure.